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Mitochondrial NADH dehydrogenase from bovine heart was photolabelled with the inhibitor [3H]dihydro- 
rotenone. A constituent ofthe hydrophobic domain of the enzyme ofMr 33 000 was the major site of label- 
ling. The identity of this protein with the mitochondrially encoded ND-I gene product was established by
immunoblotting and immunoprecipitation with an antiserum raised to the expected C-terminal sequence 
of the human ND-1 gene product. 
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1. INTRODUCTION 
Seven of the reading frames of the mammalian 
mitochondrial genome have been shown recently 
to encode subunits of the respiratory chain NADH 
dehydrogenase [1,2]. The putative amino acid se- 
quences of these proteins are available for several 
species, not only mammalian (e.g. [3]), but in- 
terspecies comparisons have not suggested any ob- 
vious role for these proteins in NADH 
dehydrogenase function despite regions of se- 
quence which are strongly conserved [3]. For ex- 
ample, none of these ND gene products contain 
sufficient numbers of conserved cysteines to be 
iron-sulphur proteins [3] while the FMN- 
containing subunit of the enzyme is almost certain- 
ly nuclear-encoded [3]. However, the sequences are 
mostly hydrophobic and suggest he presence of 
several transmembrane or-helical regions. It is 
highly likely therefore that some of these subunits 
are in direct contact with the bilayer lipid and 
might therefore serve to bind hydrophobic ligands 
which partition into the hydrocarbon region of the 
membrane. Possible ligands are the substrate, 
ubiquinone-10, and inhibitors such as rotenone 
and piericidin which are believed to act very close 
to the site of ubiquinone-10 reduction [4]. 
In previous work we had attempted to identify 
the NADH dehydrogenase subunit involved in 
rotenone binding by photoaffinity labelling. A 
photoactivatable rotenone analogue, arylazido- 
amorphigenin, specifically labelled a protein of Mr 
33000 in purified beef heart NADH dehydrogen- 
ase (complex I) [5]. The low specific radioactivity 
of the arylazidoamorphigenin hampered further 
studies, but here we show that this protein can be 
photolabelled directly by [3H]dihydrorotenone to a 
much higher specific activity. Using an antibody 
directed against the C-terminal sequence of the 
human ND-1 product [6] we also show that this 
rotenone-binding protein is mitochondrially 
encoded. 
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2. MATERIALS AND METHODS 
Complex I was prepared as in [7]. Inhibition of 
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NADH-ubiquinone-1 reductase activity by rote- 
none or dihydrorotenone was measured as in [8]. 
Photolysis and determination of protein-bound 
radioactivity were carried out as in [8]. Gel electro- 
phoresis was carried out in 12-160"/0 (w/v) poly- 
acrylamide gradient gels using the Laemmli buffer 
system [9] unless otherwise indicated. Mr standards 
were from BDH Chemicals (Poole, England). 
Radioactivity in gels was determined by scintilla- 
tion counting of slices [5], or by fluorography 
using Amplify (Amersham International, Bucks, 
England) as scintillant and preflashed Kodak X- 
Omat AR film at -70°C.  Immunoblotting on 
nitrocellulose was carried out using the strepta- 
vidin-biotin system (Amersham International) for 
detection. For description of the immunoprecipita- 
tion procedure refer to the legend to fig.4. 
Dihydrorotenone was synthesized by hydrogena- 
tion of rotenone in ethyl acetate using 10°70 Pd/C 
as catalyst. [3H]Dihydrorotenone (spec. act. 
58 Ci/mmol) was synthesised by Amersham Inter- 
national in the same way. The crude material 
(3 mCi) was dried down under N2, dissolved in 
100/A acetonitri le/H20 (60:40, v/v) and applied 
to a Waters Resolve reverse-phase C~s column, 
developed with the same solvent and monitored at 
295 nm. The major absorbing species had a reten- 
tion time identical to that of unlabelled 
dihydrorotenone. This material was collected and 
diluted with cold dihydrorotenone to give final 
specific activities as indicated. 
3. RESULTS 
The possibility that rotenone would photolabel 
its binding site was suggested by the presence in the 
structure of an arylketone (rings C and D of fig. 1), 
a group which forms a biradical upon activation by 
CH39 
C H30"I"~ 0 
o 
~otenone H ]I 
Fig.1. Structure of rotenone. 
UV light [10] and which has been used as a basis 
for photolabelling reagents. To obtain a 
radiolabeUed erivative, [3H]dihydrorotenone was 
produced by reduction of the isopropenyl side 
chain. Dihydrorotenone inhibited the NADH- 
ubiquinone-1 reductase activity of complex I with 
the same potency as rotenone, e.g. 5001o inhibition 
at 0.35 nmol/mg protein [5]. 
UV irradiation of [3H]dihydrorotenone in the 
presence of complex I gave a time-dependent i -
corporation of label into protein which, under our 
conditions, began to saturate after 20 min of il- 
TRACK 
Fig.2. Photolabelling of complex I with [3H]dihydroro- 
tenone. Complex I (3 mg/ml in 0.67 M sucrose/50 mM 
Tris-HCl, pH 8.0) was incubated with [3H]dihydrorote- 
none (1 nmol/mg protein, spec. act. 3 Ci/mmol) for 
15 min on ice and then photolysed for 30 min either 
under argon (tracks 1, 2, 4, 5) or in air (tracks 3, 6). 
Samples were dissociated in SDS either at 20°C (tracks 
1, 3, 4, 6) or 100°C (tracks 2, 5), prior to electrophoresis 
(150/zg protein/track) and fluorography. Tracks 1-3, 
fluorograph; 4-6, Coomassie blue-stained gel. 
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luminat ion.  Photolysis times were routinely varied 
between 30 and 45 min. Analysis by SDS gel elec- 
trophoresis and f luorography of  complex I labelled 
with I mol inh ib i tor /mol  enzyme revealed 
substantial  abell ing of  the 33 kDa polypept ide 
(fig.2, tracks 3,6) which had been shown in 
previous work to be preferential ly photolabel led 
by ary laz idoamorphigenin [5]. In addit ion to the 
33 kDa subunit,  some larger (51 and 42 kDa) and 
smaller subunits were also labelled, but to a much 
lesser extent. When the complex I sample was 
dissociated in SDS at 100°C (fig.2, track 2), exten- 
sive aggregation of  the labelled material  took place 
and nearly all radioact ivity was found at the 
origin. Dissociation of  complex I at 100°C also 
resulted in the loss of  the 33 kDa protein (track 5) 
presumably as a result o f  aggregation. When 
TRACK 
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Origin 
ND-I 
ND-3- 
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Fig.3. Immunoblotting of complex I and subfractions. 
Proteins were separated by SDS gel electrophoresis and 
transferred to nitrocellulose, lmmunoblotting was with a 
mixture of antibodies to the ND-I, 3 and 4L products 
(each diluted 100-fold) or, additionally, in track 2, with 
antiserum to the 30 kDa protein of complex I (1 : 100). 
Complex I was resolved with NaCIO4 (e.g. [11]) and 
separated into flavoprotein, iron protein and 
hydrophobic protein fractions. Tracks: 1,2, complex 1 
(100 #g protein); 3, hydrophobic protein (70 #g protein); 
4, iron protein (30#g protein); 5, flavoprotein (10#g 
protein). 
photolabel l ing was carried out under anaerobic 
condit ions,  more extensive labell ing of  the protein 
of  51 kDa was obtained (track 1). It seems likely 
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Fig.4. lmmunoprecipitation f labelled ND-1 product. 
Complex 1 (2 mg protein/ml) was incubated with 
[3Hldihydrorotenone (0.4 nmol/mg, 58 Ci/mmol) for 
10 min followed by photolysis for 30 rain under argon at 
0°C. The following method was adapted from that of 
Anderson and Blobel [121. The protein (100#g) was 
solubilized by addition of 5 #1 of 25% (w/v) SDS and 
200#1 of a mixture containing 1.25% (w/v) Triton 
X-100, 190 mM NaC1, 60 mM Tris-HCl, pH 7.6, 6 mM 
EDTA. Normal serum (10 #l) was added and incubated 
for 4 h at 4°C. Fixed S. aureus (100#1 of a 10% 
suspension) was added and mixed for 1 h at room 
temperature. After centrifugation, the supernatant was 
treated with 50/A anti-ND-1 product antiserum for 16 h 
at 4°C and then absorbed with 500#1 of 10% S. aureus 
for 1 h at room temperature. The S. aureus was washed 
three times with 1 ml of a mixture containing 145 mM 
NaCI, 50 mM Tris-HCl, pH 7.5, 5 mM EDTA, 0.1% 
(w/v) Triton X-100, 0.02% (w/v) SDS by centrifugation 
and resuspension. After a further wash in detergent-free 
buffer, the cells were suspended in 50,,1 of 0.5 M Tris- 
HCI, pH 6.8, 50#1 10% (w/v) SDS and 50#1 of 10% 
(v/v) 2-mercaptoethanol and incubated at 37°C for 
40 rain. The supernatant fraction was separated by 
electrophoresis on a 12.5% polyacrylamide cylindrical 
gel (11 cm × 5 mm i.d.) using the buffer system 
described in [13]. After staining and destaining, the gel 
was sliced into 1 mm slices for scintillation counting. 
The Weber and Osborne [13] buffer system provides 
excellent separation of the 33 and 30 kDa polypeptides 
[11]; a parallel gel pattern of complex I was used as a 
molecular mass marker. 
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that labelling of this protein was suppressed by ox- 
ygen which is a radical scavenger. From similar ex- 
periments in which the gel was sliced and counted 
for radioactivity, it was established that the 
recovery of radioactivity on the gel was only 
5-10% of that added to the enzyme. The low 
degree of incorporation of the label was a problem 
encountered in the related work with 
arylazidoamorphigenin [5]. 
The 33 kDa protein is a constituent of the 
hydrophobic domain of complex I which is 
associated with the membrane lipid [3,11]. This 
property is shared with the ND-I gene product. As 
shown in fig.3, immunoblotting with antiserum to 
the C-terminal undecapeptide of the human ND-1 
product specifically identifies the ND-1 product as 
a protein of 33 kDa (track 1), distinct from the 
closely migrating subunit of 30 kDa (track 2) and 
located exclusively in the hydrophobic domain of 
the enzyme (tracks 3-5). Moreover, the ND-1 
product is aggregated following dissociation of
complex I in SDS at 100°C (not shown). 
Definite proof of the identity of the rotenone- 
labelled protein with the ND-1 gene product was 
obtained from the experiment of fig.4. Complex I, 
photolabelled to a high specific activity with 
[3H]dihydrorotenone, was dissociated in SDS and 
Triton and the ND-1 product immunoprecipitated 
by addition of antiserum and fixed S. aureus.  
Analysis by SDS gel electrophoresis revealed a ma- 
jor radiolabelled species of 33 kDa, and a minor 
species of much lower molecular mass which might 
be a proteolytic breakdown product. 
4. DISCUSSION 
The product of the mitochondrial gene ND-1 
(previously URF-1) was first identified by im- 
munoprecipitation from labelled HeLa cell 
mitochondria as a protein of apparent Mr 24000 on 
SDS-urea gels as estimated relative to water- 
soluble marker proteins [6]. The subsequent 
assignment of this and other mitochondrial gene 
products to NADH dehydrogenase [1,2] has en- 
abled us to identify this protein directly in the 
purified bovine heart enzyme by immunoblotting. 
The undecapeptide used as antigen differs by only 
three amino acids from the equivalent bovine se- 
quence [14,15]. The Mr of 33 000, determined using 
the Laemmli buffer system, is very close to the 
value of 35 675 predicted from the amino acid se- 
quence [15]. 
Our previous conclusion from using arylazido- 
amorphigenin that the 33 kDa subunit was the site 
of rotenone binding was qualified by the low 
recovery of label on the SDS gel [5]. While the 
same problem applies to the use of dihydrorote- 
ilone, the labelling of the same subunit by two 
photolabels whose structure, site of photoactiva- 
tion and photochemistry are quite different, pro- 
vides much more compelling evidence in favour of 
our original proposal. Dihydrorotenone seems 
rather less specific than arylazidoamorphigenin; 
however, the appearance of label in other polypep- 
tides need not be ascribed only to nonspecific 
binding but rather it may reflect the participation 
of other proteins in forming the rotenone-binding 
site. 
The identification of seven mitochondrial gene 
products as subunits of NADH dehydrogenase has 
been hitherto rather indirect. The parallel im- 
munoprecipitation f these proteins by antiserum 
to complex I [1] or the 49 kDa iron-sulphur protein 
subunit [21 and the demonstration by immunoblot- 
ting of three of these proteins (the ND-1, 3 and 4L 
products) in isolated complex I could be ascribed 
to their fortuitous association with the enzyme. 
However, the immunoprecipitation by a mono- 
specific antiserum of a protein labelled with a 
dehydrogenase inhibitor provides direct evidence 
that the ND-1 gene product is a dehydrogenase 
subunit and, moreover, one which may be in- 
timately involved in the enzyme's function. It may 
be significant, in this connection, that ND~ is the 
most conserved evolutionarily among the mito- 
chondrially encoded subunits of NADH dehydro- 
genase [16], and that its gene has been found in all 
mitochondrial genomes so far analysed from 
organisms which exhibit site 1 energy coupling 
[171. 
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